Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Best Formulations operates as a fully licensed drug and nutraceutical manufacturing facility. It has achieved six consecutive 'A' ratings in NSF cGMP audits, underscoring its commitment to quality and compliance. The company offers advanced manufacturing capabilities including soft gels, tablets, capsules, powders, teas, drugs, and most recently state-of-the-art gummy production with dedicated R&D labs and automated lines.
In July 2022 Sirio Pharma acquired a majority stake in the company. Integration into Sirio’s global network has expanded its reach and capabilities.
No clinical results are reported since the company does not develop proprietary therapeutics but manufactures products for clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Best Formulations.